| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |